SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

YIELD10 Bioscience, Inc. – ‘10-Q’ for 9/30/22 – ‘ZIP’

On:  Monday, 11/14/22, at 4:14pm ET   ·   For:  9/30/22   ·   Accession #:  1121702-22-49   ·   File #:  1-33133

Previous ‘10-Q’:  ‘10-Q’ on 8/10/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/12/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/14/22  YIELD10 Bioscience, Inc.          10-Q        9/30/22   60:4.8M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    548K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: R1          Cover                                               HTML     69K 
11: R2          Condensed Consolidated Statements of Operations     HTML     85K 
                Unaudited                                                        
12: R3          Condensed Consolidated Balance Sheets Unaudited     HTML    112K 
13: R4          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Loss Unaudited                                                   
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     89K 
                Unaudited                                                        
16: R7          Condensed Consolidated Statements of Stockholders'  HTML     81K 
                Equity                                                           
17: R8          Accounting Policies                                 HTML     51K 
18: R9          Nature of Business and Basis of Presentation        HTML     32K 
19: R10         Basic and Diluted Net Loss Per Share                HTML     28K 
20: R11         Investments                                         HTML     37K 
21: R12         Fair Value Measurements                             HTML     50K 
22: R13         Accrued Expenses                                    HTML     27K 
23: R14         Stock-Based Compensation                            HTML     37K 
24: R15         Leases                                              HTML     46K 
25: R16         Commitments and Contingencies                       HTML     27K 
26: R17         License Agreements                                  HTML     21K 
27: R18         Geographic Information                              HTML     42K 
28: R19         Capital Stock and Warrants                          HTML     42K 
29: R20         Accounting Policies (Policies)                      HTML     93K 
30: R21         Accounting Policies (Tables)                        HTML     37K 
31: R22         Basic and Diluted Net Loss Per Share (Tables)       HTML     26K 
32: R23         Investments (Tables)                                HTML     36K 
33: R24         Fair Value Measurements (Tables)                    HTML     47K 
34: R25         Accrued Expenses (Tables)                           HTML     26K 
35: R26         Stock-Based Compensation (Tables)                   HTML     35K 
36: R27         Leases (Tables)                                     HTML     44K 
37: R28         Geographic Information (Tables)                     HTML     39K 
38: R29         Capital Stock and Warrants (Tables)                 HTML     43K 
39: R30         ACCOUNTING POLICIES - Additional Information        HTML     35K 
                (Details)                                                        
40: R31         ACCOUNTING POLICIES - Schedule of Cash And          HTML     27K 
                Restricted Cash (Details)                                        
41: R32         Nature of Business and Basis of Presentation        HTML     20K 
                (Details)                                                        
42: R33         Basic and Diluted Net Loss Per Share (Details)      HTML     27K 
43: R34         Investments (Details)                               HTML     30K 
44: R35         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     45K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
45: R36         Accrued Expenses (Details)                          HTML     29K 
46: R37         Stock-Based Compensation (Details)                  HTML     82K 
47: R38         Stock-Based Compensation - RSU Activity (Details)   HTML     28K 
48: R39         LEASES - Narrative (Details)                        HTML     31K 
49: R40         LEASES - Maturity Analysis of Lease Liabilities     HTML     38K 
                (Details)                                                        
50: R41         LEASES - Quantitative Disclosure of Lease Costs     HTML     33K 
                (Details)                                                        
51: R42         Commitments and Contingencies (Details)             HTML     32K 
52: R43         Geographic Information (Details)                    HTML     31K 
53: R44         CAPITAL STOCK AND WARRANTS - Narrative (Details)    HTML     39K 
54: R45         CAPITAL STOCK AND WARRANTS - Schedule Of Warrants   HTML     34K 
                Issuance (Details)                                               
55: R46         CAPITAL STOCK AND WARRANTS - Schedule of Common     HTML     25K 
                Stock Reserved For Future Issuance (Details)                     
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- yten-20220930_htm                   XML   1.11M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     74K 
 6: EX-101.CAL  XBRL Calculations -- yten-20220930_cal               XML    135K 
 7: EX-101.DEF  XBRL Definitions -- yten-20220930_def                XML    311K 
 8: EX-101.LAB  XBRL Labels -- yten-20220930_lab                     XML   1.05M 
 9: EX-101.PRE  XBRL Presentations -- yten-20220930_pre              XML    584K 
 5: EX-101.SCH  XBRL Schema -- yten-20220930                         XSD     96K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              296±   420K 
60: ZIP         XBRL Zipped Folder -- 0001121702-22-000049-xbrl      Zip    189K 


‘ZIP’   —   XBRL Zipped Folder — 0001121702-22-000049-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:ex-311x20220930.htm
ex-312x20220930.htm
ex-321x20220930.htm
yten-20220930.htm
yten-20220930.xsd
yten-20220930_cal.xml
yten-20220930_def.xml
yten-20220930_lab.xml
yten-20220930_pre.xml


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/24/23  YIELD10 Bioscience, Inc.          424B5                  1:587K


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  YIELD10 Bioscience, Inc.          10-Q        3/31/22   59:4.5M
 3/25/22  YIELD10 Bioscience, Inc.          10-K       12/31/21   83:9.4M
Top
Filing Submission 0001121702-22-000049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 11:37:05.1am ET